Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Covetrus Q2 EPS $(0.03) May Not Compare To $0.25 Estimate, Sales $1.21B Miss $1.22B Estimate

Author: Michael Horton | August 04, 2022 08:42am
Covetrus (NASDAQ:CVET) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $0.25 by 112 percent. This is a 111.54 percent decrease over earnings of $0.26 per share from the same period last year. The company reported quarterly sales of $1.22 billion which missed the analyst consensus estimate of $1.22 billion by 0.25 percent. This is a 2.35 percent increase over sales of $1.19 billion the same period last year.

Posted In: CVET

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist